ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO094

Comparison of Measured versus Online Urea Kinetics in Patients with AKI Undergoing Hemodialysis

Session Information

Category: Acute Kidney Injury

  • 003 AKI: Clinical and Translational

Authors

  • Bhatti, Owais, Washington University St Louis, Saint Louis, Missouri, United States
  • Zhang, Yifei Frank, Washington University St Louis, Saint Louis, Missouri, United States
  • Vijayan, Anitha, Washington University St Louis, Saint Louis, Missouri, United States
Background

In patients with acute kidney injury (AKI) on intermittent hemodialysis (HD), KDIGO guidelines recommend a target single pool Kt/V (spKt/V) of 1.3, three times per week. Currently, the standard method of monitoring dialysis adequacy is by calculating spKt/V using pre and post serum BUN. This requires additional blood draws which are associated with nursing labor and laboratory costs. Online urea kinetic monitor systems, such as continuous dialysate UV-adsorbance monitoring, can potentially measure real time spKt/V without added cost. Unlike ESRD, AKI patients have fluctuating volume of distribution of urea and data on online urea monitoring in AKI are scarce.

Methods

We instituted a QI project to compare online monitoring to measured Kt/Vurea. After approval from the Washington University IRB we conducted a retrospective analysis of this data. For a single dialysis session per patient, spKt/V was calculated via Daugirdas equation, and compared to Kt/V measured by dialysate online urea monitoring. All patients underwent HD using B.Braun Dialog+(R) machines. Data were analyzed using Bland-Altman analysis.

Results

We reviewed 43 dialysis treatments of 20 patients with AKI. The mean age was 53 years, 60 % (12) were men and 65 % (13) had ATN. Bland- Altman analyses of the data showed that both methods were in agreement (Fig 1).

Conclusion

In this pilot study, data suggest that spKt/V calculated via pre and post serum BUN is comparable to the Kt/Vurea measured by continuous dialysate monitoring using UV-adsorbance. This has major implications regarding cost savings while ensuring that AKI patients are receiving adequate dialysis. A larger prospective study is needed to determine whether online urea kinetics monitoring can be substituted for measured Kt/Vurea in patients with AKI.

Figure 1